Exodus Point Capital Management, LP Evolus, Inc. Transaction History

Exodus Point Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$7.23 - $10.52 $1.93 Million - $2.81 Million	-266,765 Reduced 56.75%	203,283 $1.48 Million
Q1 2023 May 11, 2023	BUY	$7.81 - $11.05 $1.11 Million - $1.57 Million	142,328 Added 43.43%	470,048 $3.98 Million
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.95 $1.97 Million - $2.7 Million	302,220 Added 1185.18%	327,720 $2.46 Million
Q3 2022 Nov 10, 2022	BUY	$7.76 - $13.72 $197,880 - $349,860	25,500 New	25,500 $205,000
Q4 2021 Feb 11, 2022	SELL	$5.37 - $8.38 $243,481 - $379,957	-45,341 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $333,709 - $619,811	45,341 New	45,341 $345,000
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $636,608 - $3.28 Million	-198,940 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.92 - $4.84 $467,778 - $775,358	160,198 Added 413.5%	198,940 $668,000
Q3 2020 Nov 16, 2020	BUY	$3.03 - $5.48 $117,388 - $212,306	38,742 New	38,742 $151,000
Q3 2019 Nov 14, 2019	SELL	$13.91 - $19.87 $280,773 - $401,075	-20,185 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $266,240 - $572,446	20,185 New	20,185 $295,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.